Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,975 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,975 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,975 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,975 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,975 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,975 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,975 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
Deykin Aaron Chief Medical Officer
Sold at will
$8.31K 894 at 9.29
2.7%
Not planned
16 Mar 2026
Sold at will
$8.09K 9,700 at 0.83
1.4%
Not planned
16 Mar 2026
GRAY MICHAEL CFO and COO
Sold at will
$7.92K 852 at 9.29
2.8%
Not planned
16 Mar 2026
Harris Robert E. Chief Accounting Officer
Sold at will
$7.58K 665 at 11.40
7.4%
Not planned
16 Mar 2026
Houghton Adam Chief Business Officer
Sold at will
$6.49K 699 at 9.29
2.8%
Not planned
16 Mar 2026
Coen Steven P. See remarks
Sold at will
$4.77K 708 at 6.74
7.2%
Not planned
16 Mar 2026
Nonko Eugene Director · indirect
Sold at will
$4.58K 458 at 10.00
0.0%
Not planned
16 Mar 2026
Griffith Jesse Chief Operations Officer
Sold at will
$4.50K 1,402 at 3.21
3.2%
Not planned
16 Mar 2026
Ambrose Allison General Counsel
Sold at will
$4.41K 475 at 9.29
2.8%
Not planned
16 Mar 2026
Vazzano Joseph Walter Chief Financial Officer
Sold at will
$3.74K 785 at 4.76
0.1%
Not planned
16 Mar 2026
Stevens Jennifer Chief Regulatory Officer
Sold at will
$3.19K 774 at 4.12
0.6%
Not planned
16 Mar 2026
Cox Bryan F. Chief of Research
Sold at will
$2.39K 579 at 4.12
0.4%
Not planned
16 Mar 2026
Marshak Richard Chief Commercial Officer
Sold at will
$1.73K 419 at 4.12
0.4%
Not planned
16 Mar 2026
Devlin Jodi Chief of Clinical Operations
Sold at will
$1.12K 273 at 4.12
0.3%
Not planned
16 Mar 2026
MAROONE MICHAEL E Director · indirect
Sold at will
$621.52 2 at 310.76
0.8%
Not planned
13 Mar 2026
Sold at will
$16.45M 380,000 at 43.30
1.5%
Not planned
13 Mar 2026
Vivas Eduardo Director
Sold at will
$9.59M 20,910 at 458.67
0.3%
Not planned
13 Mar 2026
VINCIARELLI PATRIZIO Chairman and CEO
Sold at will 11×
$8.54M 50,000 at 170.86
0.5%
Not planned
13 Mar 2026
Will W Anthony Director
Sold at will 2×
$6.94M 53,026 at 130.83
49.1%
Not planned
13 Mar 2026
Rodgers Thurman J Director · indirect
Sold at will
$5.99M 137,250 at 43.61
7.9%
Not planned
13 Mar 2026
Cochran Caroline Co-Founder, COO · indirect
Sold at will
$4.38M 72,960 at 60.00
8.8%
Not planned
13 Mar 2026
DeWitte Jacob Co-Founder, CEO
Sold at will
$4.38M 72,960 at 60.00
8.8%
Not planned
13 Mar 2026
Bealmear Richard Craig Chief Financial Officer
Sold at will
$4.33M 72,090 at 60.00
15.7%
Not planned
13 Mar 2026
LUNDQUIST ANDREW D Senior Vice President
Sold at will
$4.13M 34,500 at 119.68
66.4%
Sold half or more
13 Mar 2026
Sold at will
$4.09M 80,776 at 50.64
29.7%
Not planned
13 Mar 2026
Zmigrosky Matt EVP, Chief Legal and Admin Off
Sold at will
$3.76M 20,899 at 180.00
25.7%
Not planned
13 Mar 2026
Lish Scott CHIEF OPERATING OFFICER
Sold at will
$3.20M 260,535 at 12.30
24.2%
Not planned
13 Mar 2026
Cochran Caroline Co-Founder, COO
Sold at will
$2.69M 44,828 at 60.00
5.9%
Not planned
13 Mar 2026
DeWitte Jacob Co-Founder, CEO · indirect
Sold at will
$2.69M 44,828 at 60.00
5.9%
Not planned
13 Mar 2026
Cuddy Christopher M Senior Vice President
Sold at will
$2.57M 35,000 at 73.50
9.6%
Not planned
13 Mar 2026
Pinner Ian R Senior Vice President
Sold at will
$2.44M 34,106 at 71.53
27.3%
Not planned
13 Mar 2026
YOUNG MORRIS S CEO · indirect
Sold at will
$1.94M 37,905 at 51.13
1.6%
Not planned
13 Mar 2026
Yeganeh Reuven Director · indirect
Sold at will
$1.85M 370,000 at 5.00
100%
Sold half or more
13 Mar 2026
DONAHUE THOMAS R VP, CFO & Treasurer
Sold at will
$1.71M 30,000 at 57.10
4.8%
Not planned
13 Mar 2026
COGHILL CLINT D Director · indirect
Sold at will
$1.71M 256,232 at 6.66
7.3%
Not planned
13 Mar 2026
Dorosh Dmitriy Principal Accounting Officer
Sold at will 2×
$1.41M 3,109 at 453.42
2.7%
Not planned
13 Mar 2026
Saggar Rajeev Chief Medical Officer
Sold at will
$1.28M 35,365 at 36.30
16.9%
Not planned
13 Mar 2026
Jergensen Joshua President & COO
Sold at will
$1.25M 36,335 at 34.28
1.3%
Not planned
13 Mar 2026
Margolis Joseph D Chief Executive Officer · indirect
Sold at will
$1.07M 7,500 at 142.08
10.1%
Not planned
13 Mar 2026
Lukes David R President & CEO
Sold at will
$1.07M 39,749 at 26.80
6.3%
Not planned
13 Mar 2026
Mujica Hernan E. CHIEF TECHNOLOGY OFFICER
Sold at will
$850.00K 5,000 at 170.00
24.3%
Not planned
13 Mar 2026
BAUR MICHAEL L CEO, President, BOD Chair
Sold at will 2×
$757.19K 21,173 at 35.76
11.6%
Not planned
13 Mar 2026
Cooper Jeffrey Elliott Chief Financial Officer
Sold at will
$755.03K 4,757 at 158.72
6.5%
Not planned
13 Mar 2026
Sold at will
$747.33K 21,129 at 35.37
25.7%
Not planned
13 Mar 2026
Barkmann Albert Exec. VP and Chief Engineer
Sold at will
$731.60K 4,000 at 182.90
12.7%
Not planned
13 Mar 2026
SINGH RAMAN Director
Sold at will
$720.83K 20,000 at 36.04
34.0%
Not planned
13 Mar 2026
Davis Lisa Ann Director
Sold at will
$662.62K 3,800 at 174.37
30.4%
Not planned
13 Mar 2026
Eilers Meghan Nicole EVP, M&M & GC
Sold at will
$634.46K 11,582 at 54.78
17.6%
Not planned
13 Mar 2026
Krepp Sarah Chief Human Resource Officer
Sold at will
$617.92K 16,261 at 38.00
9.9%
Not planned
13 Mar 2026
KELLY THOMAS J Chief Financial Officer
Sold at will
$617.76K 8,000 at 77.22
11.5%
Not planned
Showing 13,601–13,650 of 22,975. ← Newer Page 273 of 460 Older →